covid-19 prevention symptomatic

Monoclonal antibodies protect against COVID-19 in a second study

Reading now: 153
www.sciencemag.org

Jon CohenScience’s COVID-19 reporting is supported by the Pulitzer Center and the Heising-Simons Foundation.A second company has provided preliminary evidence that proactively infusing healthy people with monoclonal antibodies against SARS-CoV-2 prevents them from developing noticeable symptoms of COVID-19 if they are exposed to the coronavirus.

In a press release today, Regeneron revealed that when it gave a cocktail of two of those antibodies to 186 people living in a house with someone who had COVID-19, none developed symptomatic disease.The trial is ongoing, and the results have not yet posted as a preprint, let alone been published in a peer-reviewed journal.

Read more on sciencemag.org
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA